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Choropleth maps are commonly used in cancer reports 
and community discussions about cancer rates. Cancer reg-
istries increasingly use geographic information system tech-
niques. The Centers for Disease Control and Prevention’s 
Division  of  Cancer  Prevention  and  Control  convened  a 
Map Work Group to help guide application of geographic 
information  system  mapping  techniques  and  to  promote 
choropleth mapping of data from central cancer registries 
supported by the National Program of Cancer Registries, 
especially  for  planning  and  evaluation  of  comprehensive 
cancer control programs. In this 2-part series in this issue 
of Preventing Chronic Disease, we answer frequently asked 
questions about choropleth map design to display cancer 
incidence data. We recommend that future initiatives con-
sider more advanced mapping, spatial analysis, and spatial 
statistics techniques, and include usability testing with rep-




Maps are an effective tool for cancer control planning and 
evaluation (1-3). Data displayed on a map allow users to 
visualize spatial relationships and draw attention to areas 
of importance. Maps can be used to identify boundaries of 
complex geography, display rates for specific areas, reveal 
geographic patterns, and suggest questions for research 
(eg, what is the spatial relationship between cancer rates 
and risk factors such as socioeconomic status?) (1).
 
The  National  Program  of  Cancer  Registries  (NPCR), 
Division  of  Cancer  Prevention  and  Control  (DCPC), 
Centers for Disease Control and Prevention (CDC) sup-
ports state central cancer registries (CCR) in the collection 
of high-quality cancer incidence data (4). An increasing 
number of these registries assign geocodes (eg, latitude 
and  longitude  coordinates)  to  residential  addresses  of 
people with incident cases (5,6). These geocoded cases can 
be used to develop maps of cancer incidence rates and as 
part of spatial statistical analyses (7).
 
Choropleth maps are a common starting point for map-
ping cancer incidence. DCPC convened a Map Work Group 
to  develop  guidance  for  the  design  of  choropleth  maps 
and to promote mapping of NPCR-supported CCR cancer 
incidence data. Choropleth maps of cancer incidence rates 
assign colors to rate categories and then fill the area in 
the geographic units of interest (eg, states, counties, cen-
sus tracts) with the color corresponding to that unit’s rate 
(8). The National Cancer Institute (NCI) and CDC state 
cancer profiles Web site provides good examples of choro-
pleth maps (9). Many more advanced mapping methods 
exist, but these methods typically require investment in 
additional  software  or  training  for  state  program  staff 
(7,10,11).
 
This 2-part series summarizes Map Work Group respons-
es to common questions about choropleth map design. In 
this article we discuss the purpose of the map, geographic 
units  of  analysis,  cancer  sites,  age-adjusted  rates,  rate 
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ratios, and reliability.  In Part 2 we discuss suppression 
rules; questions related to mapping cancer stage, rates, 
and percentages; classes for map display; comparing maps 
over time; map color schemes, labels, projections, and out-
put media; and limitations in interpretation (12). 
Frequently Asked Questions About 
Choropleth Map Design
1. What is the purpose of the map?
 
Map  design  requires  consideration  of  the  audiences 
to  which  the  map  will  be  presented,  the  purpose  that 
the map serves for each audience, and plans to provide 
supplemental information to help interpret the map. For 
example, in the context of comprehensive cancer control, 
multiple audiences potentially exist, including community 
members, policy makers, clinicians, geographers, epidemi-
ologists, and state comprehensive cancer control staff. For 
internal program use by CCR staffers who have signed an 
agreement to protect privacy and confidentiality of cancer 
data, maps can be useful to show point locations of cancer 
cases.  However,  to  protect  privacy  and  confidentiality, 
this type of map would not be distributed to the public. 
Similarly, although maps developed with advanced geo-
graphic information systems methods (eg, adaptive spatial 
filtering) can be used to engage community participation 
(11), such maps may require that the map maker meet 
with community representatives to explain the methods 
used and how to interpret the map.
 
Sharing  maps  with  end  users  during  development 
ensures that the content, meaning, and audience inter-
pretation are appropriate. More formal usability testing 
may be helpful, especially when requesting user feedback 
on Web applications with maps (13). The same map may 
not be equally suited for all audiences or be able to answer 
all questions. A single map may lead end users to request 
additional maps. More than 1 map or different types of 
maps in addition to tables, graphs, and explanatory text 
may be needed to answer all of the questions posed by a 
specific audience.
 
Maps are especially useful to help users visualize the 
answers to “where” questions and questions about spatial 
relationships. Such questions are commonly asked as part 
of state comprehensive cancer control planning and evalu-
ation (1), for example:
• Where are high-priority populations for cancer preven-
tion interventions?
• Where are cancer screening services provided?
• Where  do  preventable  cancers  occur,  especially   
advanced-stage cases?
• Are  there  gaps  between  the  locations  of  high- 
priority populations and locations where cancer preven-
tion services are provided?
• What is the cancer incidence rate for a specific area?
• Where are areas with unusually high or low rates?
• Are the geographic patterns on a map caused by normal 
random variation?
• How do spatial patterns in cancer incidence rates change 
over time?
• What is the spatial correlation between geographic pat-
terns for cancer incidence rates and those for cancer risk 
factors?
2. Are some geographic units of analysis more advanta-
geous than others for choropleth cancer incidence maps?
 
In 2003, Boscoe and Pickle (14) reviewed 12 geographic 
units that can be used for choropleth maps of cancer inci-
dence data and identified the following characteristics as 
desirable:
• high degree of resolution
• homogeneity of population size
• homogeneity of land area
• observation of minimum population thresholds and land 
area thresholds
• temporal stability and currency
• compactness of shape
• audience familiarity
• data availability
• the functional relevance of the unit to the phenomena 
mapped
 
They concluded that 1) each of the 12 geographic units 
had  some  advantages  and  disadvantages;  2)  depending 
on the specific study question, some units may be prefer-
able to others; and 3) none of the units was optimal for all 
purposes (14). For national maps of the continental United 
States, they assigned highest ratings to states, counties, 
and  the  Health  Service  Areas  used  in  CDC’s  Atlas  of 
United States Mortality (14,15).
 
In addition to the units reviewed by Boscoe and Pickle 
(14), Hao et al (16) suggest that presentation of cancer VOLUME 7: NO. 1
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data using congressional district boundaries may be useful 
in communicating with legislators and persuading them 
to enact new cancer control programs and to strengthen 
existing ones. Because many congressional districts do not 
follow state or county boundaries, Hao et al (16) describe a 
method to estimate age-adjusted death rates for congres-
sional districts by using county-level data.
Other investigators have concluded that analyses using 
geographic units at the subcounty level would be advanta-
geous. For example, Goodman et al (17) define primary 
care service areas based on US zip codes where Medicare 
beneficiaries  prefer  to  receive  primary  care.  California 
has mapped advanced-stage colon cancer cases by using 
medical  service  study  areas,  based  on  aggregations  of 
census tracts that local communities considered “rational 
service areas” for primary health care (18). Gregorio et al 
(19) suggest that, except for investigations focused on a 
specific cancer cluster in a limited geographic area, spatial 
analysis  at  the  census  tract  level  might  be  a  sufficient 
resolution for surveillance of cancer spatial patterns in a 
single state.
 
An additional consideration in choice of geographic unit 
may be the ability to use geography to accurately link can-
cer incidence data with census demographics, risk factors, 
and other data. In 2002, Krieger et al (20) concluded that 
census tract or block group units were better than zip codes 
for analyses of US socioeconomic inequalities in health.
3. What cancer sites would be good starting points for 
illustrating how cancer registry data may be used to help 
answer cancer prevention and control questions?
 
The Map Work Group recommended breast, colorectal, and 
cervical cancer as reasonable starting points for the devel-
opment of cancer incidence maps for comprehensive cancer 
control. These cancers can be prevented by implementation 
of the US Preventive Services Task Force (USPSTF) recom-
mendations for community preventive services and clinical 
interventions  (21).  The  USPSTF  recommends  screening 
men and women aged 50 years or older for colorectal cancer; 
biennial screening mammography for women aged 50 to 74 
years; and screening for cervical cancer in women who have 
been sexually active and have a cervix. 
 
Other cancer sites and types of data also may be of inter-
est. For example:
• For a specific state, any high-priority cancer identified in 
the state comprehensive cancer control plan (22).
• For lung cancer, maps and geographic analyses of trends 
in tobacco use by high school students (23).
4. What types of questions are best addressed by maps 
showing incident cancer case counts, unadjusted (crude) 
rates, direct age-adjusted rates, or indirect age-adjusted 
rates?
 
Presenting cancer case counts in a table with the geo-
graphic unit (eg, county) as the row can be a useful starting 
point for cancer prevention and control discussions. On the 
basis of information in the table, a choropleth map of case 
counts can be developed. However, because case counts 
are often proportional to population size, decision makers 
may ask questions that require tables showing the case-to-
population ratio or rate by geographic unit and choropleth 
maps designed on the basis of that information.
 
Rates for many cancers increase with age, and differ-
ences in the population age distribution in different areas 
can influence the observed crude cancer rates in each area. 
To control for such differences, direct and indirect methods 
can be used for age adjustment (sometimes referred to as 
age standardization) (11,24,25).
 
The direct age-adjusted rate is calculated by multiplying 
the age-specific crude rates for the local study population 
(eg, for a county) by the corresponding age-specific propor-
tion weight for the standard population (eg, for a state) 
and  then  summing  these  products.  Direct  age-adjusted 
rates are reported in the NCI/CDC State Cancer Profiles 
and in United States Cancer Statistics reports, using the 
national population as the standard (9,26).
 
In contrast, the indirect age-adjusted method estimates 
the expected cases in the local study area (eg, a county) by 
multiplying the number of people in an age category for 
the local study area population by the corresponding age-
specific rates of the standard population (eg, the state). 
Expected cases then are summed across age groups and 
compared  with  the  actual  or  observed  number  of  cases 
in  the  local  study  population.  The  ratio  of  observed  to 
expected cases takes into account age distribution because 
both the observed and expected cases are based on the age 
distribution of the local study population.
 
If the goal is to compare cancer rates in different local 
study populations, direct age-adjusted rates are needed. VOLUME 7: NO. 1
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Indirect age adjustment does not allow rates in different 
local study populations to be compared because indirect 
age-adjusted rates are not based on a common age dis-
tribution. However, the indirect age-adjustment method 
can  be  advantageous  when  the  local  study  population 
age groups are too small to calculate stable, local age-
specific  rates,  as  in  sparsely  populated  rural  counties 
(11).  As  summarized  by  Beyer  and  Rushton,  indirect 
age-adjustment  “applies  the  stable  statewide  rate  to 
local populations, instead of applying local disease rates, 
which for small areas are unstable, to standard popula-
tion weights” (11).
 
For questions about allocation of resources, tables of case 
counts and maps of age-specific rates may be more useful 
than age-adjusted rates because the case counts and age-
specific rates are actual measures of risk within the spe-
cific area of interest. In contrast, direct age-adjusted rates 
are relative indexes, and hypothetical rates reflect the age 
distribution  of  the  selected  standard  population  rather 
than the actual number of people in each age category in a 
specific community. A potential limitation of indirect age-
adjusted rates for purposes of resource allocation is that 
each local area applies a different set of weights reflecting 
the age distribution of its population. On the other hand, 
as  Beyer  and  Rushton  point  out,  local  decision  makers 
may find indirect age-adjusted rates useful because “the 
difference between actual and expected numbers of late-
stage cancer cases is a measure of the need for additional 
resources such as screening services” (11).
5. When calculating and evaluating county-to-state rate 
ratios to identify specific counties with higher or lower 
rates than the state rate, how should the denominator for 
the rate ratio be defined when the index county of inter-
est has a relatively large population compared with other 
counties in that state?
 
In 2008, 16 counties (in 15 states) accounted for 25% 
or more of the total population in their state. Examples 
of such counties are Clark County, Nevada (71.8% of the 
state population); Maricopa County, Arizona (60.8%); Cook 
County, Illinois (41.0%); Salt Lake County, Utah (37.4%); 
King  County,  Washington  (28.6%);  and  Los  Angeles 
County, California (26.8%) (27).
 
County-to-state rate ratios are calculated as the ratio of 
the rate for an index county of interest to the state rate. 
The state rate can potentially be calculated with the index 
county excluded (State Rate 1) or with the index county 
included (State Rate 2).
 
State Rate 1 (excluding the index county) is advanta-
geous from a statistical perspective because the numera-
tor rate (the index county rate) and denominator rate (the 
state rate excluding the index county) are independent. 
The  statistical  assumption  of  nonoverlapping  groups  is 
not violated.
 
State Rate 2 (including the index county) allows overlap   
between the numerator rate (the index county rate) and 
the denominator rate (the state rate including the index 
county). However, if county-to-state rate ratios are needed 
for every county in a state, the State Rate 2 approach is 
easier to calculate than the State Rate 1 approach. Using 
the State Rate 2 approach, the rate for each index county 
is compared with the same denominator (the state rate 
including the index county). In contrast, using the State 
Rate 1 (excluding the index county) approach, a different 
state rate needs to be calculated with the selection of each 
index county.
 
The Map Work Group concluded that the following rule 
of thumb may be helpful in deciding which approach would 
be appropriate. The state rate can be calculated with the 
index county included (State Rate 2) if the population of 
the index county accounts for less than 25% of total state 
population. However, if the population of the index county 
accounts for 25% or more of the total state population, 
then the state rate should exclude the index county (State 
Rate 1). When an index county accounts for 25% or more of 
the total state population, inclusion of the index county in 
the state rate can result in a reported county-to-state rate 
ratio that is less than the true county-to-state rate ratio 
by at least 10%.
6. How should information about reliability (eg, unstable 
rates) be displayed on a map?
 
Several methods exist to display information about reli-
ability of rates on a map. One option uses different shades 
of gray to indicate map areas with small numbers, unsta-
ble rates, or missing data. If colors are used to indicate 
areas with stable rates, areas shaded gray tend to remain 
in the background.
 
A second option employs hatched lines to convey rate 
variance. The hatched lines allow the underlying spatial VOLUME 7: NO. 1
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patterns to be seen. The Atlas of United States Mortality 
(14) illustrates how double-hatching with parallel white 
and black lines can be used over light and dark colors.
 
A third method, proposed by Carr and colleagues (28,29), 
provides confidence intervals in addition to mapped rates. 
The mapped rates are ranked, confidence intervals are cal-
culated around each rate, and a graph of the ranked rates 
with their confidence intervals is then displayed adjacent 
to micromaps of the rates. This approach is used in the 
Comparative  Data  Display  section  of  the  State  Cancer 
Profiles (9).
 
A fourth option is the use of funnel plots. Funnel plots 
show increasing population size on the x-axis, and higher 
and lower bounds for predicted limits for rates on the y-
axis around a horizontal line corresponding to the overall 
rate (30,31). The predicted limits decrease as population 
size increases, resulting in a graph with a shape similar 
to that of a funnel. Outliers for geographic units of differ-
ent population sizes are identifiable as the rates located 
outside the predicted limits.
Conclusion
 
Design of high-quality, effective choropleth maps of can-
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